Canadian biotech company Lexaria Bioscience has announced positive findings from a study that could potentially allow Denmark’s Novo Nordisk to reduce production costs for its type 2 diabetes and obesity drugs. The study revealed that Lexaria DehydraTECH-processed semaglutide is just as effective as the semaglutide that serves as the active…
Shares of GeoVax Labs, a biotechnology company developing a monkeypox treatment, soared more than 50% early on Monday, August 19. The jump came after disappointing study results for another monkeypox treatment developed by SIGA Technologies. In addition, last week the World Health Organization (WHO) declared a public health emergency due…
Ahead of expected rate cuts, small-cap stocks have started to “show signs of life,” notes the Motley Fool. It suggests that if the Fed achieves a “soft landing” — that is, lowering rates while avoiding a recession — small caps could outperform large caps and offers three of the best…
Sidus Space, a space company aiming to create a constellation of 3D-printed satellites, saw its shares surge more than 37% on Thursday, August 15. The gains were primarily driven by upbeat industry news, as satellite designer and manufacturer AST SpaceMobile reported strong results, explained Freedom Broker senior analyst Yegor Tolmachev.…
Shares of fintech company DeFi Technologies surged more than 13% in OTC trading on Thursday, August 15. The company reported its “strongest financial quarter to date” and raised its full-year revenue guidance by approximately 50%. Details DeFi Technologies stock rose 13.3% to $1.70 per share in OTC trading on Thursday.…
Shares of Well Health Technologies, which owns outpatient health clinics in Canada and develops healthcare IT platforms, rose nearly 4% on the Toronto Stock Exchange today, Thursday, August 15. The company reported record revenue and profit for the second quarter and raised its annual guidance. Details On the Toronto Stock…
“Essentially, we are interested in three things — a strong balance sheet, a record of success as a business, and the potential for a profitable future,” says Chuck Royce, the long-time portfolio manager and the namesake of Royce Investment Partners. Over half a century ago, Royce was one of the…
Shares of Ideanomics, an electric vehicle company, resumed their decline in OTC trading on Wednesday, August 14, after crashing over 60% and then rebounding 50% over the last few days. The stock initially plummeted after the U.S. SEC announced a settlement of fraud charges against Ideanomics and three of its…
The fair value of BioStem Technologies, a manufacturer of perinatal tissue-based treatments, should be nearly 80% higher than the current share price, according to Zacks Small-Cap Research (Zacks SCR). BioStem has seen rapid growth recently, and its second-quarter 2024 earnings beat expectations, Zacks SCR points out. BioStem stock rose 8.4%…
Goldman Sachs Asset Management, which manages over $2 trillion in assets, is looking to buy tech and small-cap stocks following the U.S. equities selloff and amid an expected normalization in rates. Details “What we’re looking at now is: can we buy some select tech names and the small-caps space,” said…
Shares of hearing implant developer Envoy Medical surged almost 20% on Monday, August 12. Before the market opened, the company reported its second-quarter 2024 results and announced that, after 18 months of preliminary research on its cochlear implant — which essentially replaces the function of the inner ear — it…
Sonoma Pharmaceuticals, which develops treatments for dermatological conditions and advanced wound care with its flagship product stabilized hypochlorous acid, saw its stock plunge almost 20% on Friday, August 9. The losses followed the release of worse than expected quarterly financial results. Details Sonoma stock fell 19.7% on Friday to $0.25…
Shares of VolitionRx, a company that develops early-detection tests for serious diseases, fell over 7% on Friday, August 9. This came after the company announced a direct offering in which it plans to sell up to $21.5 million of new shares and warrants to an undisclosed investor. Details VolitionRx stock…
Innodata, a U.S. provider of IT services and enterprise software, saw its stock surge more than 21% in premarket trading on Friday, August 9. The gains followed the announcement of record revenue growth of 66% in the second quarter, as well as upgraded guidance for the year. Details On Friday,…
Shares of Viemed Healthcare, a company that provides in-home respiratory support and has a market capitalization of $278.7 million, rose nearly 10% on Thursday, August 8. The day before, the company reported upbeat earnings for the second quarter of 2024: net revenue had its best quarterly performance ever, having risen…
Citius Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) had approved its lymphoma drug LYMPHIR. This marks the first FDA approval for the drug developer. Despite this, quotes on Citius Pharmaceuticals shares plummeted 17% after the opening bell, followed by a slight rebound later. Earlier this week, Citius…
On Wednesday, August 7, Canada’s KITS Eyecare, a retailer of eyewear and contact lenses, reported that its revenue grew 26% to a record CAD37.9 million (approximately $27.6 million) in the second quarter of 2024. Quotes on KITS shares closed 5% higher on the Toronto Stock Exchange. Details The company’s revenue…
“A caravan of combine harvesters chew up the grassland under the open prairie sky. They hum along in staggered rows, on the way to fill up grain elevators in the distance. The air smells like a combination of a bakery, brewery, and grassland,” Lionel Kambeitz, cofounder of Canada’s Above Food,…
The explosive growth of the AI market has taken many tech stocks to record highs, but the Motley Fool argues that there are still hidden gems out there, highlighting three companies in particular: processor manufacturer AMD, cybersecurity company SentinelOne, and IT service provider Innodata. Each of them, though differing in…
Shares of the biotechnology company Equillium, with a market capitalization of $25.7 million, surged over 15% on Tuesday, August 6. The trigger was positive interim results from the trial of its drug for graft-versus-host disease (GvHD), a condition in which a donor’s immune cells attack a recipient’s body, recognizing it…
Nonlethal weapons manufacturer Byrna Technologies may repurchase up to $10 million of its stock under a new buyback program. At the start of trading on Monday, August 5, quotes on Byrna were on the rise but eventually ended the session down 2%. Details In the report filed with the U.S.…
Citius Pharmaceuticals, a developer of drugs for bloodstream infections, lymphoma, and hemorrhoids, is one step closer to spinning off its oncology business as a separate Nasdaq-listed company. On Monday, August 5, shares of Citius Pharma rose nearly 3% on the news, despite a broader market selloff. Details Citius Pharma, with…
On Friday, August 2, IES Holdings, which designs and installs integrated electrical and technology systems for a variety of end markets, released its results for the fiscal-2024 third quarter (ended June 30) and announced that the board of directors had approved a new $200 million stock buyback program. This announcement,…
Quotes on shares of Inuvo, a provider of AI-driven advertising technology, rose almost 3.5% on Thursday, August 1, following the announcement of a new $10 million credit line. Details Inuvo stock added 3.45% to $0.32 per share during trading in New York on Thursday. It has lost 26% so far…
